FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 744 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer MOST POPULAR FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative... February 27, 2025 3D-Printed Surgical Guides Are Helping Surgeons Save More Breast Tissue While... December 2, 2020 Outcomes of Cancer Patients with SARS-CoV-2 Infection in Veneto August 20, 2020 Tisagenlecleucel Is Safe and Effective in Pretreated Patients with Relapsed/Refractory Follicular... December 21, 2021 Load more HOT NEWS Longest Follow-Up of CAR T-Cell Therapy in Mantle Cell Lymphoma Points... Teenage (…and young adult) kicks Cuando necesita ayuda con responsabilidades de cuidado Cancer in My Community: Caring for Children With Cancer in Paraguay
